Variable | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
OR (95%CI) | P value | OR (95%CI) | P value | |
Age (%) | 0.65 (0.23–1.87) | 0.426 | ||
Sex (%) | 1.13 (0.42–3.02) | 0.803 | ||
BMI (%) | 0.93 (0.17–5.15) | 0.937 | ||
Clinical T stage (%)* | 1.40 (0.48–4.11) | 0.538 | ||
Clinical N stage (%)* | 1.12 (0.21–6.05) | 0.891 | ||
Neutrophil count (N) | 0.76 (0.56, 1.04) | 0.0902 | ||
Platelet count (P) | 1.00 (0.99, 1.00) | 0.5999 | ||
NLR | 0.82 (0.61, 1.09) | 0.1712 | ||
PLR | 125.0 (90.9, 166.7) | 0.5512 | ||
Hemoglobin (Hb) | 0.99 (0.98, 1.01) | 0.5182 | ||
Albumin (Alb) | 0.95 (0.82, 1.10) | 0.5181 | ||
AFP | 1.04 (0.89, 1.23) | 0.6057 | ||
CEA | 1.00 (0.97, 1.03) | 0.8507 | ||
CA125 | 1.08 (1.01, 1.16) | 0.0098 | 1.11 (1.02, 1.20) | 0.0123 |
CA242 | 1.00 (1.00, 1.01) | 0.4783 | ||
CA199 | 1.00 (1.00, 1.00) | 0.9661 | ||
CA724 | 1.01 (0.98, 1.03) | 0.4865 | ||
Tumor location (%) | 2.92 (0.91, 9.44) | 0.0426 | 10.61 (1.34, 84.22) | 0.254 |
Lauren classification (%) | 0.21 (0.06, 0.75) | 0.0163 | 0.40 (0.18, 0.88) | 0.0219 |
CLDN18.2 | 0.86 (0.76, 0.97) | 0.0169 | 0.86 (0.75, 0.99) | 0.0301 |
Tumor differentiation type (%) | 0.12 (0.01, 1.11) | 0.0416 | 0.03 (0.00, 2.17) | 0.1096 |